Stemmer-Rachamimov AO - Search Results

1

Histology-based expression profiling yields novel prognostic markers in human glioblastoma.

Dong S, Nutt CL, Betensky RA, Stemmer-Rachamimov AO, Denko NC, Ligon KL, Rowitch DH, Louis DN. Dong S, et al. J Neuropathol Exp Neurol. 2005 Nov;64(11):948-55. doi: 10.1097/01.jnen.0000186940.14779.90. J Neuropathol Exp Neurol. 2005. PMID: 16254489 Free PMC article.

2

Meningioangiomatosis is associated with neurofibromatosis 2 but not with somatic alterations of the NF2 gene.

Stemmer-Rachamimov AO, Horgan MA, Taratuto AL, Munoz DG, Smith TW, Frosch MP, Louis DN. Stemmer-Rachamimov AO, et al. J Neuropathol Exp Neurol. 1997 May;56(5):485-9. doi: 10.1097/00005072-199705000-00004. J Neuropathol Exp Neurol. 1997. PMID: 9143261 Review.

3

Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system.

Stemmer-Rachamimov AO, Gonzalez-Agosti C, Xu L, Burwick JA, Beauchamp R, Pinney D, Louis DN, Ramesh V. Stemmer-Rachamimov AO, et al. J Neuropathol Exp Neurol. 1997 Jun;56(6):735-42. J Neuropathol Exp Neurol. 1997. PMID: 9184664

4

Histopathologic and immunohistochemical prognostic factors in malignant gliomas.

Stemmer-Rachamimov AO, Louis DN. Stemmer-Rachamimov AO, et al. Curr Opin Oncol. 1997 May;9(3):230-4. doi: 10.1097/00001622-199709030-00003. Curr Opin Oncol. 1997. PMID: 9229144 Review.

5

Universal absence of merlin, but not other ERM family members, in schwannomas.

Stemmer-Rachamimov AO, Xu L, Gonzalez-Agosti C, Burwick JA, Pinney D, Beauchamp R, Jacoby LB, Gusella JF, Ramesh V, Louis DN. Stemmer-Rachamimov AO, et al. Am J Pathol. 1997 Dec;151(6):1649-54. Am J Pathol. 1997. PMID: 9403715 Free PMC article.

6

The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix.

Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, Louis DN, Gavin BJ, Kley N, Kaelin WG Jr, Iliopoulos O. Ohh M, et al. Mol Cell. 1998 Jun;1(7):959-68. doi: 10.1016/s1097-2765(00)80096-9. Mol Cell. 1998. PMID: 9651579 Free article.

7

Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.

Stemmer-Rachamimov AO, Ino Y, Lim ZY, Jacoby LB, MacCollin M, Gusella JF, Ramesh V, Louis DN. Stemmer-Rachamimov AO, et al. J Neuropathol Exp Neurol. 1998 Dec;57(12):1164-7. doi: 10.1097/00005072-199812000-00008. J Neuropathol Exp Neurol. 1998. PMID: 9862639

8

The hPMS2 exon 5 mutation and malignant glioma. Case report.

Taylor MD, Perry J, Zlatescu MC, Stemmer-Rachamimov AO, Ang LC, Ino Y, Schwartz M, Becker LE, Louis DN, Cairncross JG. Taylor MD, et al. J Neurosurg. 1999 May;90(5):946-50. doi: 10.3171/jns.1999.90.5.0946. J Neurosurg. 1999. PMID: 10223463

9

Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues.

Nielsen GP, Stemmer-Rachamimov AO, Shaw J, Roy JE, Koh J, Louis DN. Nielsen GP, et al. Lab Invest. 1999 Sep;79(9):1137-43. Lab Invest. 1999. PMID: 10496532

10

Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation.

Nielsen GP, Stemmer-Rachamimov AO, Ino Y, Moller MB, Rosenberg AE, Louis DN. Nielsen GP, et al. Am J Pathol. 1999 Dec;155(6):1879-84. doi: 10.1016/S0002-9440(10)65507-1. Am J Pathol. 1999. PMID: 10595918 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters